Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

DaxibotulinumtoxinA Injection for Treatment of Adductor Spasmodic Dysphonia

NCT05158166 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.

NCT NCT05158166
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05158166 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
DaxibotulinumtoxinA Injection for Treatment of Adductor Spasmodic Dysphonia
Lead sponsor
University of California, San Francisco
Phase
Phase 1/2
Overall status
Completed
Start date
October 13, 2023
Completion date
March 2, 2025
Enrollment
22 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adductor spasmodic dysphonia, spasmodic dysphonia, voice disorders